Skip to content
10-Q

Quarterly Report

CHINA-BIOTICS, INC

0001144204-12-069601

← back to feed
Filed
Dec 26, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Dec 24, 2012 22.15M sh
Shares Diluted Q2 2012 · Sep 30, 2012 22.36M sh
Shares Diluted Q2 2012 · Sep 30, 2012 22.34M sh
Operating Cash Flow Q2 2012 · Sep 30, 2012 $7.74M
Short Term Debt Q2 2012 · Sep 30, 2012 $3.96M
Short Term Debt Q2 2012 · Mar 31, 2012 $3.17M
Cash And Equivalents Q2 2012 · Sep 30, 2012 $55.49M
Cash And Equivalents Q2 2012 · Mar 31, 2012 $70.09M
Stockholders Equity Q2 2012 · Sep 30, 2012 $210.87M
Stockholders Equity Q2 2012 · Mar 31, 2012 $202.43M
Current Liabilities Q2 2012 · Sep 30, 2012 $47.63M
Current Liabilities Q2 2012 · Mar 31, 2012 $49.78M
Total Liabilities Q2 2012 · Sep 30, 2012 $51.9M
Total Liabilities Q2 2012 · Mar 31, 2012 $54.53M
Current Assets Q2 2012 · Sep 30, 2012 $91.88M
Current Assets Q2 2012 · Mar 31, 2012 $106.99M
Total Assets Q2 2012 · Sep 30, 2012 $262.77M
Total Assets Q2 2012 · Mar 31, 2012 $256.96M
Eps Diluted Q2 2012 · Sep 30, 2012 $0.26
Eps Diluted Q2 2012 · Sep 30, 2012 $0.35
Eps Basic Q2 2012 · Sep 30, 2012 $0.26
Eps Basic Q2 2012 · Sep 30, 2012 $0.35
Sga Expense Q2 2012 · Sep 30, 2012 $3.94M
Sga Expense Q2 2012 · Sep 30, 2012 $7.6M
Net Income Q2 2012 · Sep 30, 2012 $5.72M
Net Income Q2 2012 · Sep 30, 2012 $7.79M
Operating Income Q2 2012 · Sep 30, 2012 $5.9M
Operating Income Q2 2012 · Sep 30, 2012 $8.31M
Gross Profit Q2 2012 · Sep 30, 2012 $12.42M
Gross Profit Q2 2012 · Sep 30, 2012 $22.52M
Cost Of Revenue Q2 2012 · Sep 30, 2012 −$7.73M
Cost Of Revenue Q2 2012 · Sep 30, 2012 −$15.01M